Biltmore Family Office, LLC Merck & Co., Inc. Transaction History

Biltmore Family Office, LLC

$528 Million
Q2 2024

A detailed history of Biltmore Family Office, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Biltmore Family Office, LLC holds 55,227 shares of MRK stock, worth $5.73 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

55,227

Previous 53,623 2.99%

Holding current value

$5.73 Million

Previous $7.08 Million 3.36%

% of portfolio

1.29%

Previous 1.43%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$123.8 - $132.96 $198,575 - $213,267	1,604 Added 2.99%	55,227 $6.84 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $33,961 - $36,957	339 Added 0.64%	53,623 $5.85 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $7,618 - $8,460	74 Added 0.14%	53,284 $5.49 Million
Q2 2023 Aug 07, 2023	BUY	$108.61 - $118.38 $3,584 - $3,906	33 Added 0.06%	53,210 $6.14 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $883,019 - $985,269	8,578 Added 19.23%	53,177 $5.66 Million
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $8,918 - $11,435	102 Added 0.23%	44,599 $4.95 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $25,189 - $28,298	298 Added 0.67%	44,497 $3.86 Million
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $40,659 - $46,089	487 Added 1.11%	44,199 $4.06 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $276,324 - $309,741	-3,759 Reduced 7.92%	43,712 $3.62 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $292,372 - $366,234	4,045 Added 9.31%	47,471 $3.67 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $73,400 - $80,721	-1,024 Reduced 2.3%	43,426 $3.29 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $20,671 - $22,864	294 Added 0.67%	44,450 $3.49 Million
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $9,089 - $10,706	132 Added 0.3%	44,156 $3.43 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $2.36 Million - $2.62 Million	32,934 Added 296.97%	44,024 $3.63 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $2,927 - $3,318	-40 Reduced 0.36%	11,090 $927,000
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $352 - $400	5 Added 0.04%	11,130 $867,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $1.56 Million - $2.16 Million	-24,610 Reduced 68.87%	11,125 $863,000
Q4 2019 Feb 05, 2020	BUY	$77.58 - $87.54 $71,606 - $80,799	923 Added 2.65%	35,735 $3.27 Million
Q3 2019 Oct 16, 2019	BUY	$76.08 - $82.93 $936,696 - $1.02 Million	12,312 Added 54.72%	34,812 $2.95 Million
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $48,818 - $57,031	-699 Reduced 3.01%	22,500 $1.9 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $105,819 - $122,801	1,622 Added 7.52%	23,199 $1.79 Million
Q3 2018 Oct 30, 2018	SELL	$57.69 - $67.84 $9,807 - $11,532	-170 Reduced 0.78%	21,577 $1.54 Million
Q2 2018 Jul 17, 2018	SELL	$50.83 - $59.72 $10,928 - $12,839	-215 Reduced 0.98%	21,747 $1.33 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $1.13 Million - $1.35 Million	21,962	21,962 $1.25 Million

Others Institutions Holding MRK

# of Institutions

3,805

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $263B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Merck & Co., Inc. Transaction History